Osimertinib

Category Pipeline API

Details	Specifications
CAS Number	1421373-66-1
Molecular Formula	C28H33N7O2.CH4O3S
Molecular Weight	595.7 g/mol.
Synonyms	N-(2-{2-(dimethylamino)ethylamino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide mesylate salt
Chemical Name	N-(2-{2-(dimethylamino)ethylamino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide mesylate salt
Therapeutic use	Osimertinib is to treat advanced or recurrent cancers with BRCA mutations, including ovarian, fallopian tube, peritoneal, HER2-negative breast, pancreatic, and prostate cancers. It functions by preventing cancer cells from repairing their DNA, causing them to die.
Status	Tech pack available
Background	Osimertinib mesylate (commonly sold under the brand name Tagrisso) is a third-generation, oral, irreversible Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor (TKI). Developed by AstraZeneca, it is specifically designed to target the T790M resistance mutation for non-small cell lung cancer (NSCLC)
Grade	In-house
Polymorph	Form-B
Storage Temperature	Controlled room temperature (20?C ? 25?C)

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Osimertinib are also Available for

Questions & Answers

FAQ on Osimertinib

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.